August 16, 2009
August 9, 2009
August 2, 2009
July 26, 2009
July 19, 2009
July 12, 2009
June 28, 2009
June 21, 2009
June 14, 2009
June 07, 2009
May 31, 2009
May 24, 2009
May 17, 2009
May 10, 2009
May 03, 2009
April 26, 2009
April 19, 2009
April 12, 2009
April 5, 2009
March 29, 2009
March 22, 2009
March 15, 2009
March 8, 2009
March 1, 2009
February 22, 2009
February 15, 2009
February 8, 2009
February 1, 2009
January 25, 2009
January 18, 2009
January 11, 2009
December 21, 2008
December 14, 2008
December 7, 2008
|
|
|
|
|
|
 |
Live Sundays · 1-3pm PT · 4-6pm ET
|
|
A Post-ASCO Discussion of
an Ovarian Cancer Study
|
This
Sunday in The Group Room
we'll focus on one of the studies that was just recently presented at the annual
meeting of the American Society of Clinical Oncology (ASCO) and has since
provoked a lot of reaction from ovarian cancer patients and advocates. It
suggests that earlier detection and treatment of recurrent disease using the
CA125 test does not impact survival or benefit clinical outcome. We'll be
joined by leading physicians on this topic, The Ovarian Cancer National
Alliance, and women living with ovarian cancer. We invite you to share your own
thoughts, questions and concerns on this controversial study here in TGR at
1-800-GRP-ROOM, and visit our new
show website at www.thegrouproom.tv.
Special guests on this feature broadcast with host
Selma R. Schimmel, CEO &
Founder of Vital Options International, will be:
Beth Y. Karlan, MD - Hour 1Board of Governors Endowed Chair and Director of the Women's Cancer Research Institute and Division of Gynecologic Oncology at Cedars-Sinai Medical Center, Professor of Obstetrics and Gynecology at David Geffen School of Medicine at UCLA, Past-President of the Society of Gynecologic Oncology, and Editor-in-Chief of the Journal of Gynecologic Oncology Andrew Berchuck, MD - Hour 2Director
of the Duke University Medical Center, Division of Gynecologic
Oncology;, F. Bayard Carter Distinguished Professorship; NC; Former
president of the Society of Gynecologic Oncologists. Karen Orloff Kaplan, MSW, MPH, ScD
Chief Executive Officer of the Ovarian Cancer National Alliance Monica KnollExecutive Director and Founder of Cancer101, and cancer survivor Cara Tenenbaum, Esq. Senior Policy Director of the Ovarian Cancer National Alliance
|
|
Got a question for one of our
guests or have a story of your own to tell? Click here or e-mail us at info@vitaloptions.org.
Call in and participate:
1-800-GRP-ROOM · 1-800-477-7666
International
listeners!
21:00 - 23:00 GMT · 22:00
- 24:00 CET
Click here for info on how to listen to the
program outside of the U.S.
|
We are taking your story submissions! Click here to submit your own story
or a topic suggestion for an upcoming show. Next week:
Sunday, June 21
Father's Day
|
 For a complete listing of stations or to listen
to the live Internet Simulcast visit vitaloptions.org. The Group Room can be heard live every Sunday from 1-3pm PT/4-6pm ET
on select stations around the nation, streamed live online, and on XM Satellite
Radio America's Talk 158 on Sundays, 7-9p ET. Download The Group Room
podcasts on iTunes!
The Group
Room is produced
by VITAL OPTIONS®
INTERNATIONAL, a non-profit cancer communications, support and advocacy
organization, in association with Premiere Radio Networks.
|
Listen to past The Group Room shows in our new radio
player!
Missed a show? No problem! Click here to listen to past shows
free of charge. Shows are typically available within 24 hours of airing.
|
|
|
|
|
|
|
 Get Your Free
Copy Today!
Hope Begins in the Dark by Jamie
Reno
Jamie Reno, Award-winning Newsweek journalist and lymphoma survivor,
has written Hope Begins in the Dark, a
collection of 50 compelling lymphoma survivors' stories. Featuring inspiring
personal accounts from a wide range of lymphoma patients including former
professional baseball player Andres Galarraga, comedian Robert Schimmel, and
Microsoft co-founder Paul Allen, Hope Begins in
the Dark stresses the importance of self advocacy during treatment.
The publication of this book was made possible through the partnership
with Vital Options International, and an educational grant from GlaxoSmithKline.
If you would like a complimentary copy of this book courtesy of Vital
Options International and GlaxoSmithKline, please click here or visit www.vitaloptions.org.
Quantities are limited. Offer is valid while supplies last.
|
|
|
|
|
|
|
|
Email
